Trial
NCT04678336
CD123 Redirected T Cells for AML in Pediatric Subjects
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Pennsylvania
Collaborators
—
Condition
Acute Myeloid Leukemia, in Relapse
Intervention
CART123 cells
Why stopped
Administrative reasons
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-10-15